Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE)

CUSIP: 03836J102

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
6,583,303
Total 13F shares
13,469,861
Share change
+538,156
Total reported value
$467,365,016
Price per share
$34.76
Number of holders
50
Value change
+$18,770,937
Number of buys
34
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 03836J102?
CUSIP 03836J102 identifies APRE - Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE) as of Q1 2020

As of 31 Mar 2020, Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,469,861 shares. The largest 10 holders included FMR LLC, 5AM Venture Management, LLC, Redmile Group, LLC, Sectoral Asset Management Inc, JANUS HENDERSON GROUP PLC, Rock Springs Capital Management LP, BlackRock Inc., CITADEL ADVISORS LLC, VANGUARD GROUP INC, and Artisan Partners Limited Partnership. This page lists 50 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.